|
Active substance |
Nusinersen |
|
Holder |
Clinigen Group plc |
|
Status |
Closed |
|
Indication |
Infantile-onset (Type I) Spinal Muscular Atrophy (SMA) |
|
Public documents |
|
|
Last update |
31/08/2018 |
Spinraza®
Last updated on 23/04/2024